The Art of Leadership in the Emerging Biopharmaceutical Industry: Trends, Challenges, and Approaches
All Insights Register now Share this event: Share on facebook Share on twitter Share on linkedin Share on email Leadership is one of the key factors that determine the success or failure of any organization. In operating biopharmaceutical companies, developing and maintaining, leadership is especially important, as it sets the direction for the company’s growth […]
Drive Better Results: Using Technology in Your Product Commercialization Planning
All Insights Watch now Share this event: Share on facebook Share on twitter Share on linkedin Share on email Effective data management should treat enterprise information as the strategic asset it is, while providing end-to-end business oversight and paving the way to strategic capability and operational excellence. Unfortunately, many pharmaceutical companies struggle with their data […]
Strategic Planning for Medical Affairs: Adding Value Efficiently
Presented by Marina Brodsky PhD. and Diane Martire MD MPH of the KMK Star Alliance Air date: October 27, 2022 (45 mins) Watch now Medical affairs are crucial for communication of scientific information between companies and industry leaders, but the growing responsibility of the department has led to various challenges. One of these is effective […]
Ready, Set, Launch – Why Technology is Key to a Successful Product Launch
WHAT WILL YOU LEARN Learn why technology and IT readiness are critical to your next product launch Biotech companies have one chance to launch their product successfully. Data and well-integrated applications are critical to the success of your launch, especially for a company’s first launch, but the importance of technology and IT readiness are often […]
Access Granted Webinar: Transforming the Customer Access Landscape
WHAT WILL YOU LEARN Learn how to access customers in key accounts and effectively engage decision makers The healthcare market is rapidly changing due to consolidation, a shift to value-based reimbursement, and the advent of digital access to information. As a result, the skills required to access key accounts and engage key decision-makers also need […]
The Invisible Customer: How Private Equity Owned Practices are Changing the Biopharma Industry
WHAT WILL YOU LEARN How the impact of private equity acquisition and management of healthcare practices is changing the biopharma market landscape. What PE firms’ practice management strategy is, including financial objectives, ownership tenure, and exit strategy. About the implications of PE practice management on emerging customer segments for biopharma engagement and potential areas of […]
Looking Ahead in Oncology
WHAT WILL YOU LEARN KOL Panel Discusses Cell and Gene Therapy Trends Join Lisa Logan and a group of oncology experts in discussing the possibilities of CAR T-cell therapy expansion to treat solid tumors as well as the implications on the current and future landscape of treatments across tumor types. Get this content Emailed
Exploring Behavior Change
WHAT WILL YOU LEARN Behavioral science is a topic of study that in recent years has become a very good companion to help analyze findings from market research. By better understanding the underlying drivers of behavior, we can also better put into context the actions that our respondents describe during their interviews (qualitative and quantitative). […]
Exploring a Physician’s Why – A Webinar on Cognitive Interviewing
WHAT WILL YOU LEARN In seeking to understand physician treatment decision-making, we are interested in two fundamental concepts: what physicians do and why they do it. Cognitive interviewing provides a highly effective approach to exploring the physician’s treatment decision-making process without directly asking the question “why?”. In so doing, this valuable qualitative research technique gets […]
The Pandemic, Politics & Pharmaceuticals
WHAT WILL YOU LEARN While it’s no secret that the pandemic and political unrest have impacted nearly every aspect of the American economy this year, many of the changing dynamics shaping the pharmaceutical landscape have yet to be fully explored. Get this content Emailed
